GHK-Cu vs Melanotan I
A comparison of GHK-Cu and Melanotan I as melanocortin system-related peptides in cosmetic and dermal research, including mechanisms and evidence context.
A comparison of GHK-Cu and Melanotan I as melanocortin system-related peptides in cosmetic and dermal research, including mechanisms and evidence context.
Overview
GHK-Cu and Melanotan I both appear in cosmetic and dermal research, but they address entirely different mechanisms. GHK-Cu is primarily studied for collagen signaling and skin repair, while Melanotan I is studied for melanogenesis and photoprotection. They are occasionally compared in dermatology research contexts but represent distinct intervention strategies.
Mechanism Comparison
GHK-Cu acts as a copper-chelating tripeptide that influences collagen synthesis, extracellular matrix remodeling, and antioxidant signaling. Melanotan I is a synthetic analog of alpha-MSH studied for its ability to stimulate melanogenesis through MC1R receptor activity, leading to increased melanin production and potential UV photoprotection. The mechanisms share a skin focus but diverge entirely at the receptor and pathway level.
Dosing and Protocol Comparison
GHK-Cu is widely studied in topical formulations where concentration and delivery system determine efficacy, while injectable research also exists. Melanotan I has been primarily studied via subcutaneous injection in both animal models and limited human trials for photoprotection and skin cancer risk reduction in fair-skinned populations. The two compounds are rarely used in the same protocol and represent separate research questions.
Evidence Comparison
GHK-Cu has a broad and long-standing literature base in wound healing, skin biology, and collagen research. Melanotan I has more limited but higher-quality clinical research specifically in photoprotection, including formal trials. Both compounds have legitimate research histories in different dermal applications, making direct comparison less meaningful than understanding each independently.